MADISON, Wis. - Terso Solutions, Inc., a leading provider of automated inventory management solutions for healthcare and life science, today announced that Endologix, Inc. (Nasdaq: ELGX) has partnered with them for a fully automated, on-site consignment inventory program. Endologix chose Terso Solutions, Inc. because of their proven track record with both RFID solutions for medical device inventory management and cold chain security.
"The Endologix Nellix® EndoVascular Aneurysm Sealing System is a next generation treatment for abdominal aortic aneurysms (AAA). The proprietary polymer used in the Nellix procedure requires a frozen cold chain. In addition to our packaging controls we wanted to monitor polymer storage in the field to ensure supply and quality control. In Terso we found a partner with the right combination of expertise and technology." said Todd Abraham, Vice President of Operations, Endologix.
The polymer that is part of the Nellix System requires cold storage until it is ready to use. Endologix has commenced distributing and storing the Nellix System polymer at customer locations through Terso's RFID Freezers. The Radio Frequency Identification Device (RFID) technology reports to Endologix the status of the polymer units in real time, making transactions, inventory usage, temperature reporting, and expiration dates transparent, automatically tracked, and available to both Endologix and users in a secure, web-based interface.
"We are very excited to be working with Endologix on this innovative program," said Jason Rosemurgy, Vice President, Sales and Marketing, Terso Solutions, Inc. "Terso Solutions was built on our ability to manage field inventory stored in remote locations world-wide, and we look forward to working with Endologix to bring this innovative new product to market." Terso Solutions supports European operations through their facility in Mannheim, Germany, and continues to grow globally with deployments in Europe, Asia, South America, and Australia.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. Endologix focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 80%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's website at www.endologix.com.
The Nellix® EndoVascular Aneurysm Sealing System has obtained CE Mark in the EU and is only approved as an investigational device in the United States.
About Terso Solutions, Inc.
Terso Solutions, Inc. is the leading provider of automated inventory management solutions for tracking high-value medical and scientific products in healthcare and life science. Terso Solutions, Inc. is backed by 13 years of RFID product development and implementation experience. Our product line includes RFID Cabinets, Refrigerators, Freezers (-20C to -80C), RFID-enabled smart rooms, and RFID Software. Headquartered in Madison, WI, Terso Solutions is a wholly-owned subsidiary of the Promega Corporation. Additional information is available at www.tersosolutions.com.
Terso Solutions, Inc.
Web Site: http://www.endologix.com